[Use of glucocorticoid in treatment of severe acute respiratory syndrome cases]
- PMID: 12930669
[Use of glucocorticoid in treatment of severe acute respiratory syndrome cases]
Abstract
Objective: To explore the effect of glucocorticoid in the treatment for severe acute respiratory syndrome (SARS).
Methods: Clinical data of 70 patients with SARS admitted to Youan Hospital in Beijing during March to May, 2003 were analyzed.
Results: (1) Sixty-three of 70 cases of SARS recovered and seven cases died, with a case-fatality ratio of 10%. (2) Average length of hospital stay was 16.9 days for the all 70 cases, and 16.8 days for the 11 cases without glucocorticoid treatment, without statistical significance (F = 1.018, P = 0.39). (3) The other 59 cases were administered with 40 mg to 640 mg of methylprednisolone daily. (4) Average hospital stay was 15 days for the 23 cases with lower dose of 40 mg to 80 mg methylprednisolone daily, 18.5 days for the 27 cases with medium dose of 120 mg to 240 mg daily, and 17.9 days for the nine cases with higher dose of 320 mg to 640 mg daily (F = 1.018, P = 0.39).
Conclusions: Earlier use of glucocorticoid therapy with suitable doses could alleviate their clinical symptoms, improve their clinical courses, and promote the absorbance of infiltration in their lungs on chest-X-ray films for the cases with SARS. However, current clinical data showed that glucocorticoid therapy could not shorten the length of hospitalization for the cases with SARS.
Similar articles
-
[The COX regression analysis on the use of corticosteroids in the treatment of SARS].Zhonghua Yi Xue Za Zhi. 2004 Jul 2;84(13):1073-8. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15312504 Chinese.
-
[Effect of glucocorticoid with traditional Chinese medicine in severe acute aespiratory syndrome (SARS)].Zhongguo Zhong Yao Za Zhi. 2005 Dec;30(23):1874-7. Zhongguo Zhong Yao Za Zhi. 2005. PMID: 16499032 Chinese.
-
[Relationship between the severity, course, fatality of severe acute respiratory syndrome patients and the timing of hospitalization].Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Apr;25(4):308-11. Zhonghua Liu Xing Bing Xue Za Zhi. 2004. PMID: 15231197 Chinese.
-
[Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence].Zhonghua Yi Xue Za Zhi. 2004 Aug 17;84(16):1348-53. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15387943 Chinese.
-
[Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy].Zhonghua Nei Ke Za Zhi. 2004 Mar;43(3):179-82. Zhonghua Nei Ke Za Zhi. 2004. PMID: 15059370 Chinese.
Cited by
-
Advances in the treatment of novel coronavirus disease (COVID-19) with Western medicine and traditional Chinese medicine: a narrative review.J Thorac Dis. 2020 Oct;12(10):6054-6069. doi: 10.21037/jtd-20-1810. J Thorac Dis. 2020. PMID: 33209439 Free PMC article. Review.
-
Effectiveness and safety of glucocorticoids to treat COVID-19: a rapid review and meta-analysis.Ann Transl Med. 2020 May;8(10):627. doi: 10.21037/atm-20-3307. Ann Transl Med. 2020. PMID: 32566564 Free PMC article.
-
Longitudinal changes of liver function and hepatitis B reactivation in COVID-19 patients with pre-existing chronic hepatitis B virus infection.Hepatol Res. 2020 Nov;50(11):1211-1221. doi: 10.1111/hepr.13553. Epub 2020 Aug 29. Hepatol Res. 2020. PMID: 32761993 Free PMC article.
-
Corticosteroids on the Management of Coronavirus Disease 2019 (COVID-19): A Systemic Review and Meta-Analysis.Iran J Public Health. 2020 Aug;49(8):1411-1421. doi: 10.18502/ijph.v49i8.3863. Iran J Public Health. 2020. PMID: 33083317 Free PMC article. Review.
-
Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China.Int J Biol Sci. 2020 Apr 6;16(11):1846-1860. doi: 10.7150/ijbs.45018. eCollection 2020. Int J Biol Sci. 2020. PMID: 32398954 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
